戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed independently of neurons that express the gastrin-releasing peptide receptor.
2 3 and neuromedin-B receptor (NMB-R), but not gastrin-releasing peptide receptor.
3 ic bombesin receptor antagonist that targets gastrin-releasing peptide receptors.
4                                     Results: Gastrin-releasing peptide receptor affinity was high for
5                                     Blocking gastrin-releasing peptide receptor and natriuretic pepti
6  compared the preclinical performance of the gastrin-releasing peptide receptor antagonists RM2 (DOTA
7 rostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptors are both overexpress
8 rostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptors are both overexpress
9                                          The gastrin-releasing peptide receptor (BB2r) is overexpress
10            Receptor-targeted agents, such as gastrin-releasing peptide receptor (BB2r)-targeted pepti
11 lls transfected with the Gq-coupled bombesin/gastrin releasing peptide receptor, bombesin stimulated
12 is and to use bombesin analogs to target the gastrin-releasing peptide receptor for the diagnosis and
13                            The bombesin (Bn)/gastrin-releasing peptide receptor GRP-R, which is coupl
14 ed by cells expressing the G-protein-coupled gastrin-releasing peptide receptor (GRP-R) and is curren
15                                          The gastrin-releasing peptide receptor (GRP-R) is a neuropep
16                                          The gastrin-releasing peptide receptor (GRP-R) is one of thr
17 imilar rationale, radioligands targeting the gastrin-releasing peptide receptor (GRP-R) might offer a
18 ll lines were made that stably expressed the gastrin-releasing peptide receptor (GRP-R) with receptor
19 receptors (neuromedin B receptor (NMB-R) and gastrin-releasing peptide receptor (GRP-R)).
20 s by the bombesin receptor family, including gastrin-releasing peptide receptor (GRP-R), neuromedin B
21 -coupled receptors currently consists of the gastrin-releasing peptide receptor (GRP-R), neuromedin B
22 udy we demonstrate that for the G(q)-coupled gastrin-releasing peptide receptor (GRP-R), phosphorylat
23 ceptor subtypes have been characterized: the gastrin-releasing peptide receptor (GRP-R), the neuromed
24  of G-protein-coupled receptors includes the gastrin-releasing peptide receptor (GRP-R), the neuromed
25 mutagenesis to address these issues with the gastrin-releasing peptide receptor (GRP-R).
26 al, G-protein coupled receptors includes the gastrin-releasing peptide receptor (GRP-R, or bb2), neur
27 ly reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine
28                                              Gastrin-releasing peptide receptors (GRP-R) are upregula
29                Bioconjugate affinity for the gastrin releasing peptide receptor (GRPR) as determined
30                                          The gastrin releasing peptide receptor (GRPr) has a high aff
31                                              Gastrin releasing peptide receptor (GRPR) is an attracti
32 , we show that the spinal neurons expressing gastrin releasing peptide receptor (GRPR) primarily comp
33  into tumor cells, their affinity toward the gastrin releasing peptide receptor (GRPr), metabolic sta
34 e been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tum
35                                              Gastrin releasing peptide receptors (GRPR) have been sho
36           However, the limited expression of gastrin-releasing peptide receptor (GRPR) and integrin a
37            We recently introduced the potent gastrin-releasing peptide receptor (GRPR) antagonist (68
38 e treatment of prostate cancer, radiolabeled gastrin-releasing peptide receptor (GRPr) antagonists ha
39 e spinal cord to establish that NK1R and the gastrin-releasing peptide receptor (GRPR) are coexpresse
40 romosome occurred in the first intron of the gastrin-releasing peptide receptor (GRPR) gene and that
41                Because overexpression of the gastrin-releasing peptide receptor (GRPR) has been repor
42       Theranostic applications targeting the gastrin-releasing peptide receptor (GRPR) have shown pro
43 eraction between u-opioid receptor (MOR) and gastrin-releasing peptide receptor (GRPR) in spinal GRPR
44                   MOR1D heterodimerizes with gastrin-releasing peptide receptor (GRPR) in the spinal
45                                  The role of gastrin-releasing peptide receptor (GRPR) in various dis
46                        The overexpression of gastrin-releasing peptide receptor (GRPR) in various tum
47      These NK1R neurons comprise a subset of gastrin-releasing peptide receptor (GRPR) interneurons a
48                                          The gastrin-releasing peptide receptor (GRPR) is a well-know
49   Although our previous study suggested that gastrin-releasing peptide receptor (GRPR) is an itch-spe
50                                          The gastrin-releasing peptide receptor (GRPR) is found to be
51                                              Gastrin-releasing peptide receptor (GRPR) is overexpress
52                                          The gastrin-releasing peptide receptor (GRPr) is overexpress
53                                          The gastrin-releasing peptide receptor (GRPR) is overexpress
54                                          The gastrin-releasing peptide receptor (GRPR) is overexpress
55                                          The gastrin-releasing peptide receptor (GRPR) is overexpress
56                                          The gastrin-releasing peptide receptor (GRPr) is overexpress
57                                              Gastrin-releasing peptide receptor (GRPr) is phosphoryla
58                       The use of PET/CT with gastrin-releasing peptide receptor (GRPR) ligand [(68)Ga
59           We have recently developed a novel gastrin-releasing peptide receptor (GRPR) ligand with im
60     A growing body of evidence suggests that gastrin-releasing peptide receptor (GRPR) might be a val
61                    Consistently, ablation of gastrin-releasing peptide receptor (GRPR) neurons, which
62                                  Ablation of gastrin-releasing peptide receptor (GRPR) or GRPR neuron
63                    Here we describe that the gastrin-releasing peptide receptor (GRPR) plays an impor
64           In this study, we demonstrate that gastrin-releasing peptide receptor (GRPr) regulates ERK
65 he Trpv1-Cre population, depends on CGRP and gastrin-releasing peptide receptor (GRPR) transmission b
66 ckbones to generate bivalent ligands for the gastrin-releasing peptide receptor (GRPR) with a fixed d
67 -expression of Shh and BBS-cognate receptor (gastrin-releasing peptide receptor (GRPR)).
68                                              Gastrin-releasing peptide receptor (GRPR), a member of t
69 BBN) is a peptide with high affinity for the gastrin-releasing peptide receptor (GRPr), a receptor th
70 tion of the mammalian bombesin (Bn) peptide, gastrin-releasing peptide receptor (GRPR), is an excepti
71                                Its receptor, gastrin-releasing peptide receptor (GRPR), is expressed
72                    Because expression of the gastrin-releasing peptide receptor (GRPR), somatostatin
73 peptide that binds with high affinity to the gastrin-releasing peptide receptor (GRPR), which is over
74 isplay very high selectivity/specificity for gastrin-releasing peptide receptor (GRPR)-/prostate-spec
75 nd antagonistic pharmacophores targeting the gastrin-releasing peptide receptor (GRPR).
76 resents a subset of neurons that express the gastrin-releasing peptide receptor (GRPR).
77 ic bombesin receptor antagonist that targets gastrin-releasing peptide receptor (GRPr).
78 g very high selectivity and affinity for the gastrin-releasing peptide receptor (GRPr).
79 ptor (VIPR), substance P receptor (SPR), and gastrin-releasing peptide receptor (GRPR).
80 ith a population of neurons that express the gastrin-releasing peptide receptor (GRPR).
81  the spinal dorsal horn (SDH) that expresses gastrin-releasing peptide receptors (GRPR) is critical f
82 specificity of coupling interactions between gastrin-releasing peptide receptors (GRPrs) and their co
83 rostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptors (GRPRs) are both ove
84                                              Gastrin-releasing peptide receptors (GRPrs) are overexpr
85                                              Gastrin-releasing peptide receptors (GRPRs) are potentia
86                                              Gastrin-releasing peptide receptors (GRPRs) expressed on
87                           (68)Ga-RM2 targets gastrin-releasing peptide receptors (GRPRs), which are o
88                                    The human gastrin-releasing peptide receptor (hGRP-R) is aberrantl
89  of patients, demonstrating the potential of gastrin-releasing-peptide receptor imaging.
90 kinase is dependent on the expression of the gastrin-releasing peptide receptor in rat 1A fibroblasts
91 ded to understand the expression of PSMA and gastrin-releasing peptide receptors in different types o
92                                 By contrast, gastrin-releasing peptide receptor is overexpressed in E
93 icals, such as prostate-specific membrane or gastrin-releasing peptide receptor ligands for the imagi
94                                   The murine gastrin-releasing peptide receptor (mGRP-R) is a member
95 c bacteriophage P1 clones encoding the mouse gastrin-releasing peptide receptor (mGRP-R).
96  different neuropeptides for itch, including gastrin-releasing peptide receptor, natriuretic peptide
97  FITC-labeled bombesin-like peptide with the gastrin-releasing peptide receptor on PC-3 and HT-29 cel
98                                              Gastrin-releasing peptide receptors, part of the bombesi
99                                              Gastrin-releasing peptide receptor, targeted by the copp
100                             Peptides such as gastrin-releasing peptide receptors targeting radiopharm
101                              We compared the gastrin-releasing peptide receptor-targeting (68)Ga-RM2
102 BON cells or BON cells stably expressing the gastrin-releasing peptide receptor treated with either p
103 between an agonist and an antagonist for the gastrin-releasing peptide receptor were found to have ex
104 ceptors (m3 muscarinic, V1a vasopressin, and gastrin-releasing peptide receptor) were coexpressed (in

 
Page Top